Today starts classes in San Jacinto College's new center. Photo via sanjac.edu

San Jacinto College is gearing up to open the Center for Petrochemical, Energy, and Technology at its main campus in Pasadena — a $60 million project designed to bolster the Houston area's petrochemical workforce.

On August 21, the community college hosted media tours of the Center for Petrochemical, Energy, and Technology (CPET). The center will welcome more than 2,800 students August 26 and host a grand opening September 18. The college broke ground on the 151,000-square-foot center in September 2017.

At CPET, future and current petrochemical workers will learn about process operations, troubleshooting, nondestructive testing, instrumentation, and myriad other aspects of the industry. In all, CPET will offer 75 courses. The center's highlights include an 8,000-square-foot glycol distillation unit, 35 labs, and 19 classrooms. San Jacinto College bills the center as the largest petrochemical training site in the Gulf Coast region.

"Four years ago, a team came together from San Jacinto College and the East Harris County Manufacturers Association to put together a long-term plan for workforce development," says Jim Griffin, associate vice chancellor at San Jacinto College and senior vice president of petrochemical, energy, and technology. "The Center for Petrochemical, Energy, and Technology was part of that plan and is now a reality."

Griffin says the curriculum, classrooms, and labs were "designed and influenced" by the petrochemical industry.

Among CPET's more than 20 partners are:

  • Emerson, which donated more than $1.3 million worth of services and equipment.
  • INEOS Olefins & Polymers USA, which contributed $250,000 in cash.
  • Dow Chemical, which donated $250,000 in cash.

All three of those employers — and many others in the region — depend on schools like San Jacinto College to contribute to the pool of highly trained workers in the petrochemical sector.

"We expect to see a higher-than-normal level of retirements over the next five plus years; rebuilding our workforce is critical at this time," Jeff Garry, Dow Chemical's operations director in the Houston area, said when his company's CPET donation was announced. "The need to train and adequately staff our assets will continue to be a pressing concern. As the labor market becomes more competitive for talent, we understand the importance to attract and retain highly skilled and educated workers."

With four campuses in Harris County, San Jacinto College promotes itself as a training hub for the country's largest petrochemical manufacturing complex, featuring 130 plants and employing about 100,000 people. CPET will serve as the centerpiece of that hub. Overall, the community college says it "plays a vital role in helping the region maintain its status as the 'Energy Capital of the World.'"

PetrochemWorks.com — a petrochemical career initiative whose backers include JPMorgan Chase & Co., the Council for Adult and Experiential Learning, and the East Harris County Manufacturing Association — says the local petrochemical industry will need 19,000 more skilled workers annually over the next three to five years.

"Chronic shortages of skilled labor are increasing costs and schedules and resulting in declining productivity, lower quality, more accidents, and missed objectives," according to Petrochemical Update, a news website.

Although robots are on the rise in many industries, Mark Mills, a senior fellow at the Manhattan Institute who's an energy and technology expert, believes that as petrochemical companies increasingly turn to automation, productivity will go up, ultimately creating more jobs — not fewer.

"In large part," Mills writes, "it's desperation, not an infatuation with tech or cost savings, that drives employers to deploy technologies that amplify the capabilities of the employees they have and can find. It is a common misconception to think that automation is always cheaper than using labor."

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

New UH survey reveals concerns over AI data center growth in Houston

data findings

A new report out of the University of Houston shows that area residents remain wary of the long-term effects of operating data centers.

The recent survey from the University of Houston’s latest SPACE City Panel, conducted by the Center for Public Policy at the Hobby School of Public Affairs, shows that while 85 percent of Houston-area residents use AI, nearly 63 percent oppose the construction of AI data centers within 1 mile of their homes.

Respondents’ concerns centered around data centers’ high energy demand and the area’s power grid reliability. According to the survey, 32 percent of residents who oppose local data center projects would be more likely to support the centers if they relied on renewable energy over fossil fuels.

“Respondents understand that AI can bring economic and educational benefits, but they are also concerned about the physical infrastructure needed to fuel AI, especially data centers,” Soran Mohtadi, post-doctoral fellow at the Hobby School and a researcher on the report, said in a news release. “This physical infrastructure demands more electricity and water, leading to environmental impacts.”

Experts estimate that 6.5 gigawatts of data center capacity will be added to the Texas grid by 2030. And Houston’s data center capacity is predicted to more than double by 2028.

The Electric Reliability Council of Texas also projects electricity demand could reach 218 gigawatts by 2031, which would be more than double the record peak set in August 2023. Data centers are expected to account for 86 gigawatts of that new demand.

Survey respondents also said they are concerned about the state's future water supply, given the large amounts of water that data centers need to stay cool.

In terms of who’s responsible for that issue, 57.6 percent of respondents said they put the onus on Texas lawmakers, while 31.5 percent say tech companies should be responsible.

Additionally, more than 75 percent of respondents believed that data center developers and technology companies—not residents—should bear the cost of infrastructure upgrades to support data centers.

“Every decision legislators make has implications on residents’ everyday lives and local infrastructure now and in the future,” Maria P. Perez Arguelles, lead researcher on the report and research assistant professor at the Hobby School, added in the news release. “This issue is going to become more important in years to come, so this is just the beginning.”

Read the full report here.

Houston-born Cemvita makes breakthrough in sustainable fuel production

clean fuels

Houston-based biotech company Cemvita announced that it recently reached a critical milestone in the development of its FermOil product, which can be used to create Sustainable Aviation Fuel (SAF) and other renewable fuels at industrial scale.

The company shared in a news release that it completed a 75,000-liter industrial fermentation run at Belgium's Bio Base Europe Pilot Plant.

The campaign achieved target technical metrics for the production of FermOil, Cemvita’s renewable natural oil (RNO). FermOil is produced from industrial crude glycerin, an industrial byproduct, as opposed to traditional sugar-based feedstocks used in many bio-oil fermentation processes. It's designed to be a drop-in feedstock for creating SAFs.

Cemvita had previously advanced its FermOil production process through multiple scale-up stages before successfully reaching the 75,000-liter demonstration campaign, according to the company.

“This is not just a fermentation milestone,” Moji Karimi, CEO at Cemvita, said in the release. “It is a blueprint for how existing industrial infrastructure can evolve into circular bioeconomy infrastructure. Every biodiesel plant generating crude glycerin is a potential platform for renewable natural oil production.”

The milestone also supports the deployment of Cemvita’s industrial biomanufacturing platform, FermWorks, which integrates with existing energy and industrial infrastructure to turn waste carbon streams into SAFs and other materials. According to the release, Cemvita plans to move forward with commercial deployment discussions with partners in Brazil, Europe and in the UK. Cemvita already has a partnership with the Brazilian sustainable research institution REMA.

“We are proud to support innovative companies like Cemvita in scaling breakthrough industrial biotechnology solutions,” Hendrik Waegeman, head of business operations at Bio Base Europe Pilot Plant, added in the release. “Successfully operating at the 75,000-liter scale using a feedstock such as crude glycerin highlights both the maturity of the technology and the quality of the scale-up execution achieved by the Cemvita team.”

---

This article originally appeared on our sister site, EnergyCapitalHTX.com.

Eli Lilly scoops up Houston biotech startup in $300 million deal

big pharma deal

Pharmaceutical giant Eli Lilly has acquired Houston biotech startup CrossBridge Bio, which develops antibody-drug conjugates for cancer, in a deal worth up to $300 million. The deal was celebrated by TMC Venture Fund and the University of Texas Health Science Center at Houston last week.

CrossBridge, founded in 2023, is developing ADCs based on research by Kyoji Tsuchikama and Zhiqiang An, both of UT Health Houston. Tsuchikama is an associate professor of medicinal chemistry and a globally recognized ADC pioneer, and An is a professor of molecular science and vice president of drug discovery.

Antibody-drug conjugates (ADCs) are a potent combination of targeted therapy and chemotherapy that kills cancer cells while saving healthy tissue.

Clinical trials for CrossBridge’s primary ADC candidate, CBB-120, are expected to start this year, pending approval from the U.S. Food and Drug Administration (FDA).

“I’m proud of how well our team has executed and advanced our platform in such a short time since the company’s founding,” Michael Torres, co-founder and CEO of CrossBridge, said in a news release. “By becoming a part of Lilly, a leader in patient-focused therapeutic development, we are well-positioned to further accelerate the clinical potential of this approach.”

Under the Lilly deal, CrossBridge shareholders were expected to receive an upfront payment along with a follow-up payment based on the achievement of certain milestones.

In 2024, CrossBridge closed a $10 million seed round. Among the investors in CrossBridge are the Texas Medical Center Venture Fund, CE-Ventures, Alexandria Venture Investments, Portal Innovations, Linden Lake Labs, and the Cancer Prevention and Research Institute of Texas (CPRIT). It was formed in TMC Innovation’s Accelerator for Cancer Therapeutics program."Built within the TMC ecosystem, CrossBridge Bio grew with the support, funding, and resources that helped shape its trajectory. TMC led the company's early financing and watched it evolve from its earliest days to its acquisition by Eli Lilly," William McKeon, president and CEO of the Texas Medical Center, shared in a LinkedIn post. "[This is a] strong reminder that breakthrough science and the right early backing can change what’s possible."